DCCA Supports Recall On Ranitidine Medication

DCCA Supports Recall On Ranitidine Medication

(Stock Photo) The Department of Commerce and Consumer Affairs (DCCA) is again advising consumers not to use Ranitidine medication following its previous recall of October 2019. This comes against the backdrop that the Food and Drug Administration (FDA) in the United...
DCCA Supports Recall On Ranitidine Medication

Health Ministry’s Statement On Drug Recall

Statement from the Ministry of Health and Wellness on Valsartan 160mg and 320mg, and Indapamide 1.5mg Recall The Ministry of Health and Wellness wishes to inform Barbadians that recent analytical results from the Medicines Quality Control and Surveillance Department...
FDA Valsartan Recall Not Impacting Barbados

FDA Valsartan Recall Not Impacting Barbados

The Ministry of Health and Wellness is assuring the public that none of the drugs identified in the December 31 recall of the hypertensive drug, Valsartan, by the United States Food and Drug Administration (FDA) is approved by the Barbados Drug Service for sale in...
Barbados Not Affected By Valsartan Recall

Barbados Not Affected By Valsartan Recall

The Ministry of Health and Wellness has assured the public that Barbados has not been affected by the current recall of the hypertensive drug, Valsartan. The drug has been recalled due to an impurity found in a batch of products. Acting Chief Medical Officer, Dr....

Pin It on Pinterest